AcelRx Pharmaceuticals, Inc.
ACRX US00444T2096
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-55% | -81% | -67% | 16% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Angotti Vincent J. CEO |
0.59 USD |
213,310 Bought |
125,000 USD |
02/04/2025 | 02/04/2025 |
Angotti Vincent J. CEO |
0.64 USD |
5,000 Bought |
3,200 USD |
05/12/2024 | 05/12/2024 |
Asadorian Raffi CFO |
0.77 USD |
155 Sold |
119 USD |
02/12/2024 | 02/12/2024 |
Angotti Vincent J. CEO |
0.73 USD |
5,000 Bought |
3,650 USD |
27/11/2024 | 27/11/2024 |
Angotti Vincent J. CEO |
1.05 USD |
7,260 Bought |
7,598 USD |
30/08/2024 | 30/08/2024 |
Aslam Shakil CMO |
1.07 USD |
5,000 Bought |
5,357 USD |
13/06/2024 | 14/06/2024 |
Angotti Vincent J. CEO |
1.08 USD |
1,304 Bought |
1,404 USD |
12/06/2024 | 14/06/2024 |
Aslam Shakil CMO |
0.98 USD |
695 Bought |
681 USD |
13/06/2024 | 13/06/2024 |
Angotti Vincent J. CEO |
0.97 USD |
4,570 Bought |
4,438 USD |
12/06/2024 | 13/06/2024 |
Angotti Vincent J. CEO |
0.97 USD |
4,126 Bought |
4,013 USD |
12/06/2024 | 12/06/2024 |